Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329523 · ClinicalTrials.gov registry record
A Study to Compare Genetic Variations of IGF-I and IGF-II
A clinical trial, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT01329523 is a clinical trial that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 50 participants.
The verdict
NCT01329523 has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01329523
The ClinicalTrials.gov registry entry for NCT01329523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01329523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01329523 about?
NCT01329523 is a clinical study titled "A Study to Compare Genetic Variations of IGF-I and IGF-II". The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of th...
What is the current status of trial NCT01329523?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-11. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01329523?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.